Compare CBAT & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CBAT | CSBR |
|---|---|---|
| Founded | 1999 | 1985 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.9M | 83.5M |
| IPO Year | 2006 | 2015 |
| Metric | CBAT | CSBR |
|---|---|---|
| Price | $0.80 | $5.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 108.2K | 7.1K |
| Earning Date | 05-18-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 161.11 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $195,189,306.00 | $2,900,000.00 |
| Revenue This Year | $66.88 | $4.84 |
| Revenue Next Year | $41.54 | $11.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 10.52 | N/A |
| 52 Week Low | $0.70 | $5.50 |
| 52 Week High | $1.25 | $9.63 |
| Indicator | CBAT | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 48.66 | 43.33 |
| Support Level | $0.78 | $5.60 |
| Resistance Level | $0.93 | $6.31 |
| Average True Range (ATR) | 0.04 | 0.22 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 46.86 | 13.04 |
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments; CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe, India, Africa, and other regions.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.